Hikma Pharmaceuticals stock forecast
Hikma Pharmaceuticals (H5P) Stock Forecast & Price Target
H5P Analyst Ratings
H5P Stock 12 Month Forecast
Average Price Target
€23.15▲(14.93% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Beatrice Fairbairn | Berenberg Bank | €25.22→€24.62 | buy | 22.27%Upside | Reiterated | 11/09/26 | ||
| James Gordon CFA | Barclays | €20.42 | hold | 1.39%Upside | Reiterated | 11/06/26 | ||
| James Vane | Jefferies | €24.32 | buy | 20.77%Upside | Reiterated | 11/05/26 | ||
| Kane Slutzkin | Deutsche Bank | €24.62 | buy | 22.27%Upside | Reiterated | 11/03/26 | ||
| Giang Nguyen | Citi | €22.46→€21.74 | buy | 7.95%Upside | Reiterated | 10/13/26 | ||
| Zain Ebrahim | J.P. Morgan | €24.02 | buy | 19.28%Upside | Reiterated | 03/03/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Beatrice FairbairnBerenberg Bank | BuyReiterated€25.22→€24.62 | 11/09/26 | 22.27%Upside | ||
| James Gordon CFABarclays | HoldReiterated€20.42 | 11/06/26 | 1.39%Upside | ||
| James VaneJefferies | BuyReiterated€24.32 | 11/05/26 | 20.77%Upside | ||
| Kane SlutzkinDeutsche Bank | BuyReiterated€24.62 | 11/03/26 | 22.27%Upside | ||
| Giang NguyenCiti | BuyReiterated€22.46→€21.74 | 10/13/26 | 7.95%Upside | ||
| Zain EbrahimJ.P. Morgan | BuyReiterated€24.02 | 03/03/26 | 19.28%Upside |
Best Analysts Covering Hikma Pharmaceuticals
Copying Beatrice Fairbairn's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +8.98% per trade.
Copying Beatrice Fairbairn's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +15.87% per trade.
Copying Beatrice Fairbairn's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +16.18% per trade.
H5P Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 6 | 7 | 7 | 6 |
| Hold | 0 | 0 | 1 | 1 | 2 |
| Sell | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 7 | 8 | 8 | 8 |
In the current month, H5P has received 6 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. H5P average Analyst price target in the past 3 months is 23.15.
H5P Financial Forecast
H5P Earnings Forecast
Next quarter’s earnings estimate for H5P is EUR 1.00 with a range of EUR 1.00 to EUR 1.00. The previous quarter’s EPS was EUR 1.12. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
H5P Sales Forecast
Next quarter’s sales forecast for H5P is EUR 1.53B with a range of EUR 1.53B to EUR 1.53B. The previous quarter’s sales results were EUR 1.54B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

